• Home/
  • Reserch/
  • IMPACT OF PHOTOBIOMODULATION ON T3/T4 RATIO AND QUALITY OF LIFE IN HASHIMOTO THYROIDITIS

IMPACT OF PHOTOBIOMODULATION ON T3/T4 RATIO AND QUALITY OF LIFE IN HASHIMOTO THYROIDITIS

  • By admin

Objective and background: Hashimoto’s thyroiditis (HT) is both a B cell- and T cell-mediated, organ-specific autoimmune disease. No current treatment for underlying pathological mechanisms is available for HT and once diagnosed it requires long-term levothyroxine (LT4) treatment in most patients. The aim of our study was to evaluate the effects of photobiomodulation (PBM) on HT patients regarding thyroid functions, thyroid autoantibody levels, and decrease in hormone replacement needs.
Conclusions: In conclusion, our results are encouraging and PBM seems to be very effective in increasing T3/T4 ratio and decreasing TPO Ab levels and weekly dosages of LT4 replacement therapy. Anti-inflammatory properties of PBM are greatly responsible for these changes and PBM causes major improvements in HT-related symptoms of the patient.

Original Source: https://www.liebertpub.com/doi/10.1089/photob.2019.4740

Previous Blog
AN HOUR OF LIGHT AND SOUND A DAY MIGHT KEEP ALZHEIMER’S AT BAY
Next Blog
“QUANTUM LEAP” IN PHOTOBIOMODULATION THERAPY USHERS IN A NEW GENERATION OF LIGHT-BASED TREATMENTS FOR CANCER AND OTHER COMPLEX DISEASES: PERSPECTIVE AND MINI-REVIEW